Zhejiang Chinese Medicine University
Huangzhou, Zhejiang, 310000, China
NCT Number: NCT06060145
This is a randomized controlled human exposure crossover study, aims to explore the health benefits of indoor plants on cardiopulmonary system on adults.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Huangzhou, Zhejiang, 310000, China
The researchers will conduct a randomized cross-controlled trial involving 48 healthy adults in Hangzhou, China. These participants will be randomly assigned into two groups, each comprising 24 individuals. Each participant will undergo two separate exposures in an office setting: one exposure without any plants present, and another exposure with 34 to 38 potted plants. A washout period of at least 4 weeks will be implemented between the two exposures. Questionnaires, physical examinations and the collection of biological samples will be conducted prior to exposure and after exposure. In addition, the monitoring of negative air ion, air pollutants and noise exposure, as well as collection of environmental microbial samples, will be conducted on weekdays. Researchers will gather samples of blood, urine, nasal secretion, and exhaled breath condensate from participants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention group will be provided with an intervention consisting of 34-38 potted plants arranged in an office environment for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks.
Participants assigned to the control group will be exposed to an office environment devoid of any plant presence for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks.
Time frame: Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4 weeks plants exposure in second stage.
We plan to measure forced vital capacity (FVC) of lung function.
Time frame: Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4 weeks plants exposure in second stage.
We plan to measure systolic blood pressure (SBP) and diastolic blood pressure (DBP).
Time frame: Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4 weeks plants exposure in second stage.
We plan to measure Heart Rate Variability (HRV).
Time frame: Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4 weeks plants exposure in second stage.
We plan to measure serum concentrations of C-reactive protein(CRP)
Time frame: Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4 weeks plants exposure in second stage.
We plan to measure the serum concentrations of Interleukin-6
Time frame: Time Frame: Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4 weeks plants exposure in second stage.
We plan to measure the serum concentrations of Tumor necrosis factor-α
Lina Zhang
Other Gov
Effect of Indoor Plants on Cardiopulmonary System: a Randomized, Crossover, Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07427706
Apgar Score, Behavior
Tarragona, Reus, Spain
View Trial DetailsNCT07098533
Behavior, Behavioral Symptoms
Poznan, Poland
View Trial DetailsNCT04833010
Behavior, COVID-19
Frisco, Texas, United States
View Trial DetailsNCT05145192
Behavior, Cardiopulmonary
Frisco, Texas, United States
View Trial Details